Literature DB >> 16627965

Chemokine-directed metastasis.

Brigitte N Gomperts1, Robert M Strieter.   

Abstract

Over the last 20 years, the biology of chemokines has expanded beyond their initial role in mediating migration of specific subsets of leukocytes. Chemokines have been found to display pleiotropic effects for enhancing immunity to tumor-associated antigens, regulating angiogenesis, promoting proliferation/anti-apoptosis of tumor cells; and mediating tumor cell invasion and trafficking in an organ-specific manner that leads to metastases. Here, we review the importance of chemokines, especially CXC chemokines in regulating angiogenesis, tumor cell invasion and metastases; and demonstrate why they can be seen as important therapeutic targets for intervention in cancer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16627965     DOI: 10.1159/000092972

Source DB:  PubMed          Journal:  Contrib Microbiol        ISSN: 1420-9519


  9 in total

1.  The use of chemokine-releasing tissue engineering scaffolds in a model of inflammatory response-mediated melanoma cancer metastasis.

Authors:  Cheng-Yu Ko; Lanxiao Wu; Ashwin M Nair; Yi-Ting Tsai; Victor K Lin; Liping Tang
Journal:  Biomaterials       Date:  2011-10-22       Impact factor: 12.479

2.  CCL25 mediates migration, invasion and matrix metalloproteinase expression by breast cancer cells in a CCR9-dependent fashion.

Authors:  Crystal Johnson-Holiday; Rajesh Singh; Erica Johnson; Shailesh Singh; Cecil R Stockard; William E Grizzle; James W Lillard
Journal:  Int J Oncol       Date:  2011-02-23       Impact factor: 5.650

3.  Systemic targeting inhibitor of kappaB kinase inhibits melanoma tumor growth.

Authors:  Jinming Yang; Wei-Hua Pan; Gary A Clawson; Ann Richmond
Journal:  Cancer Res       Date:  2007-04-01       Impact factor: 12.701

Review 4.  Interleukin-8 in breast cancer progression.

Authors:  Nataša Todorović-Raković; Jelena Milovanović
Journal:  J Interferon Cytokine Res       Date:  2013-05-22       Impact factor: 2.607

Review 5.  Role of chemokines in tumor growth.

Authors:  Dayanidhi Raman; Paige J Baugher; Yee Mon Thu; Ann Richmond
Journal:  Cancer Lett       Date:  2007-07-12       Impact factor: 8.679

6.  Matrix metalloproteinases and tissue inhibitor of metalloproteinases are essential for the inflammatory response in cancer cells.

Authors:  Jun Sun
Journal:  J Signal Transduct       Date:  2010-07-20

7.  CCR9-CCL25 interactions promote cisplatin resistance in breast cancer cell through Akt activation in a PI3K-dependent and FAK-independent fashion.

Authors:  Crystal Johnson-Holiday; Rajesh Singh; Erica L Johnson; William E Grizzle; James W Lillard; Shailesh Singh
Journal:  World J Surg Oncol       Date:  2011-05-03       Impact factor: 2.754

8.  Angiodrastic Chemokines in Colorectal Cancer: Clinicopathological Correlations.

Authors:  George Emmanouil; George Ayiomamitis; Adamantia Zizi-Sermpetzoglou; Maria Tzardi; Andrew Moursellas; Argyro Voumvouraki; Elias Kouroumalis
Journal:  Anal Cell Pathol (Amst)       Date:  2018-04-16       Impact factor: 2.916

9.  Structural Evidence for the Tetrameric Assembly of Chemokine CCL11 and the Glycosaminoglycan Arixtra™.

Authors:  Andrew B Dykstra; Matt D Sweeney; Julie A Leary
Journal:  Biomolecules       Date:  2013-11-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.